IAM Strategy 300 names Daphne Lainson and France Leclaire among leading IP strategists for 2024

Congratulations to Daphne Lainson and France Leclaire for their inclusion in the 2024 edition of IAM Strategy 300: The World’s Leading IP Strategists. Each year, IAM Strategy 300 recognizes those who innovatively create and action strategies which realize and amplify the worth of IP portfolios.

Daphne Lainson is a principal, and the leader of firm’s Life Sciences and Chem/Bio practice group. Daphne provides strategic advice and counselling to clients across the life cycle of a drug, including during pre-clinical and clinical development through to marketing and loss of exclusivity. She is dedicated to helping innovators secure comprehensive patent protection for their chemical, pharmaceutical and biotechnology-related inventions.

France Leclaire is an accomplished patent agent and legal advisor in the Life Sciences and Chem/Bio practice group. She specializes in the life sciences sector with a focus on prosecution, client counselling, and patent portfolio growth and utilization. As a leader in her field, France regularly advises clients on biotechnology related innovations, turning their inventions into market value.

View the full 2024 list of IAM Strategy 300: The World’s Leading IP Strategists online.